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PORRECTION
n the article, “ACC/AHA Clinical Performance Measures for Adults With ST-Elevation and Non–ST-Elevation Myocardial Infarction:
Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee
o Develop Performance Measures on ST-Elevation and Non–ST-Elevation Myocardial Infarction),” by Krumholz et al., which appeared
n the January 3, 2006, issue of the journal (J Am Coll Cardiol 2006;47:236–65), the following corrections are needed:
. Table 10 (p. 256): In the entry for “Denominator,” the phrase “who received fibrinolytic therapy or primary percutaneous intervention
(PCI)” should be deleted so that it reads “AMI patients with ST-elevation on ECG.”
. In APPENDIX D (p. 261), the relationships with industry information for Dr. Eugene Braunwald is as follows.
Reviewer Name† Representation Research Grant
Speakers
Bureau/Honoraria
Stock
Ownership
Consultant/Advisory
Board
r. Eugene Braunwald ● Content Reviewer–
ACC/AHA UA/NSTEMI
Guideline Writing
Committee Chair
● Astra Zeneca
● Sanofi-Aventis
● CV Therapeutics
● Eli Lilly
● Millennium
● Schering Plough
● Nuvelo
● Pfizer
● Inotek
● Merck
● Bristol-Myers Squibb
● Astra Zeneca
● Sanofi-Aventis
● CV Therapeutics
● Eli Lilly
● Millennium
● Schering Plough
● Nuvelo
● Pfizer
● Inotek
● Merck
● Bristol-Myers Squibb
None ● Momenta
● Scios
● Biopure
● Sanofi/Synthelabo
● Schering-Plough
● Bristol-Myers Squibb
● Pfizer
● Interleuken Genetics
● Protein Design Labs
● Bayer, Ag
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